Novel behavioural approaches and implementation science for mitigating genetic risk of cardiovascular disease due to elevated lipoprotein(a)

Curr Opin Endocrinol Diabetes Obes. 2021 Apr 1;28(2):174-180. doi: 10.1097/MED.0000000000000609.

Abstract

Purpose of review: Elevated lipoprotein(a) [Lp(a)] is a genetic trait that indicates higher risk of atherosclerotic cardiovascular disease (ASCVD). We review novel strategies to mitigate behavioural risk-factors in this genetic condition.

Recent findings: Pharmacological and biological interventions are available for lowering Lp(a). However, the acceptability and feasibility of these approaches are questionable due to cost and lack of clinical evidence for their efficacy. A number of low-cost, minimal patient contact interventions are available for modifying behavioural risk-factors that are associated with increased risk of ASCVD familial hypercholesterolaemia and diabetes. These include lifestyle interventions designed to improve diet and physical activity. These interventions may be particularly important among individuals with elevated Lp(a) to manage their higher risk of diabetes and ASCVD. The following article outlines recent research that has examined such low-cost, minimal patient contact interventions.

Summary: The current research indicated that such interventions, which are grounded in psychological theory, can assist individuals to improve their diet and physical activity. These findings have implications for developing and implementing similar interventions for individuals with elevated Lp(a), so as to assist in reducing behavioural risk-factors associated with ASCVD.

Publication types

  • Review

MeSH terms

  • Cardiovascular Diseases* / genetics
  • Cardiovascular Diseases* / prevention & control
  • Humans
  • Hyperlipoproteinemia Type II*
  • Implementation Science
  • Lipoprotein(a) / genetics
  • Risk Factors

Substances

  • Lipoprotein(a)